Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Toward theragnostics.

Critical care medicine - 1 Jan 2009

Pene Frédéric, Courtine Emilie, Cariou Alain, Mira Jean-Paul

Abstract excerpt

Theragnostics is a treatment strategy that combines therapeutics with diagnostics. It associates both a diagnostic test that identifies patients most likely to be helped or harmed by a new medication, and targeted drug therapy based on the test results. Bioinformatics, genomics, proteomics, and functional genomics are molecular biology tools essential for the progress of molecular theragnostics. These tools...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Communicable Diseases
Share to Drug Design

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Hypersensitivity

Share to Major Histocompatibility Complex

Share to MicroRNAs

Share to Pharmacogenetics

Share to Validation Studies as Topic

Source

Identifiers

PMID: 19104225
DOI: 10.1097/CCM.0b013e3181921349

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Toward theragnostics.PMID 19104225Read ↗

Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.Semantic proximity Read ↗

Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care.Semantic proximity Read ↗

Systems diagnostics: anticipating the next generation of diagnostic tests based on mechanistic insight into disease.Semantic proximity Read ↗

Technology platforms for pharmacogenomic diagnostic assays.Semantic proximity Read ↗

Innovative diagnostic technologies and their significance for personalized medicine.Semantic proximity Read ↗

The integration of molecular diagnostics with therapeutics. Implications for drug development and pathology practice.Semantic proximity Read ↗

Diagnosis or drug? Will pharmaceutical companies or diagnostics manufacturers earn more from personalized medicine?Semantic proximity Read ↗

A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized TherapiesSemantic proximity Read ↗

Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.Semantic proximity Read ↗

Pharmacogenomics and rare diseases: optimizing drug development and personalized therapeuticsSemantic proximity Read ↗

[Expanding scope and impact of services provided by clinical laboratory practice through molecular diagnostics].Semantic proximity Read ↗

Personalized clinical laboratory diagnostics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.